𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer

✍ Scribed by Ki-Tae Hwang; Wonshik Han; Jihyoung Cho; Jong Won Lee; Eunyoung Ko; Eun Kyu Kim; So-Youn Jung; Eun-Mi Jeong; Ji-Yeon Bae; Jason J. Kang; Song-Ju Yang; Sung-Won Kim; Dong-Young Noh

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
462 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We tried to establish models that predict systemic recurrence in breast cancer by selecting marker clones with DNA copy number alterations (CNAs) using an array comparative genomic hybridization (CGH). Array CGH containing 4,044 human bacterial artificial chromosome clones was used to assess CNAs in 62 primary breast cancer tissues from 31 patients with systemic recurrence within 5 years after surgery and clinicopathologically well matched 31 patients who had no evidence of disease for at least 5years. Fourteen significant clones (11 clones showing gain and 3 showing loss) were identified by systemic recurrence‐free survival (SRFS) analysis and 23 significant clones (17 clones showing gain and 6 showing loss) identified by χ^2^ test and FDR test were selected as predictive markers of systemic breast cancer recurrence. The significant CNAs were found in the chromosomal regions of 5p15.33, 11q13.3, 15q26.3, 17q25.3, 18q23 and 21q22.3 with gain and 9p12, 11q24.1 and 14q32.33 with loss. We devised 2 prediction models for the systemic recurrence of breast cancer based on the 14 clones and the 23 clones, respectively. The survivals of the patients were significantly separated according to the scores from each model at the optimal cut off values in SRFS and overall survival analysis. We found candidate clones and genes of which CNAs were significantly associated with systemic recurrence of breast cancer. The devised prediction models with these clones were effective at differentiating the recurrence and nonrecurrence. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

DNA copy number alterations and expressi
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
✍ Wonshik Han; Eun-Mi Jung; Jihyoung Cho; Jong Won Lee; Ki-Tae Hwang; Song-Ju Yang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

## Abstract Triple‐negative breast cancer (TNBC) is defined by a lack of expression of estrogen, progesterone, and HER2 receptors, and genetically most of them fall into the basal subgroup of breast cancer. The important issue of TNBC is poorer clinical outcome and absence of effective targeted the

Genome profiling of breast cancer cells
Genome profiling of breast cancer cells selected against in vitro shows copy number changes
✍ Kristine Kleivi; Ragnhild A. Lothe; Sverre Heim; Haroula Tsarouha; Sigrid M. Kra 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract About 20% of breast carcinomas show no clonal chromosome abnormalities when analyzed after short‐term culturing. An interesting question is whether this subset of breast carcinomas really is karyotypically normal or if selection for normal cells occurred in vitro. To address this issue,

Integrative genomics reveals mechanisms
Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer
✍ Jordi Camps; Quang Tri Nguyen; Hesed M. Padilla-Nash; Turid Knutsen; Nicole E. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB 👁 1 views

## Abstract To evaluate the mechanisms and consequences of chromosomal aberrations in colorectal cancer (CRC), we used a combination of spectral karyotyping, array comparative genomic hybridization (aCGH), and array‐based global gene expression profiling on 31 primary carcinomas and 15 established